The emergence of COVID-19 has substantially disrupted delivery of cancer care, with postponements and cancellations of surgeries, as well as delays in systemic and radiotherapies. For patients with slow-growing tumors, these delays may be safe, but for others, waiting to start treatment can have a negative impact on outcomes. The benefits and risks of immediate […]

Atlanta, GA, and Nashville, TN – February 18, 2021 — Aptitude Health, a global healthcare and oncology solutions leader, today announced that it has entered into a strategic partnership with OneOncology, the national partnership of independent community oncologists driving the future of cancer care in the U.S. The first collaboration will incorporate Aptitude Health’s proprietary […]

Measurable (formerly minimal) residual disease, or MRD, refers to low levels of leukemia that cannot be detected by morphologic assessment alone. While not a new concept in the management of patients with leukemias, MRD testing in the management of acute myeloid leukemia (AML) has recently gained increased attention among disease-state experts. In a large-cohort meta-analysis […]

As 2019 drew to a close, pharma organizations looked forward to a blockbuster year. Analysts weighed the numbers and made predictions for 2020; but COVID-19 shattered many of their predictions. The global pandemic has led to one of the most tumultuous years in recent memory. There’s no doubt that the pandemic created upheaval in pharma […]

In 2020, COVID-19 had only a minimal effect on drug approvals, which were considerably higher in comparison with 2019. The US Food and Drug Administration (FDA) approved more than 50 new medicines and therapeutic biologics in 2020, more than a third of which were oncology/hematology treatments. Similarly, the European Medicines Agency’s Committee for Medicinal Products […]

Thanks to modern medicine, many cancer patients live longer, healthier lives. These hard-won victories have required a team effort; by working together, life science companies, clinical disease state experts, and community clinicians can dramatically improve cancer care for patients. All 3 entities play a vital role in developing life-saving treatments and ensuring that appropriate patients […]

Since the outbreak of COVID-19, telehealth has emerged as a way to continue patient care while minimizing risk of virus exposure. Interestingly, telehealth visits are not always on a screen. Many patients—particularly those who are older or have lower incomes—prefer to communicate with their providers via telephone over video visits. When parts of the US […]

The medical and pharmaceutical industries are dependent upon access to large amounts of patient data and utilizing this information in their research and the decisions they make regarding drug development and commercialization. Life science companies must continuously sift through mountains of clinical data. They are challenged with placing these data into their proper context to […]

Pancreatic cancer is one of the most difficult malignancies to manage. Multiple factors contribute to poor survival in these patients, including delayed diagnosis, rapid progression to metastatic disease, pain, and blood clots, all of which can complicate care. Outcomes have improved in recent decades, yet the current 5-year survival rate is still only 9%. The […]

2020 was an unforgettable year. COVID-19 sent shock waves across the globe, claiming more than 1.5 million lives with the end not yet in sight. In the wake of this tragedy, the pharmaceutical market raced to develop treatments. New vaccines for coronavirus have emerged in record time. In many ways, 2020 was a year of […]